JERUSALEM - Researchers believe a well-established drug could prevent lung damage in COVID-19 patients, potentially reducing the severity and mortality rate of the illness. A study started by the Hebrew University of Jerusalem in July has since demonstrated that the coronavirus inhibits the effective breakdown of fat in lungs, resulting in a buildup that can negatively impact patients. Initial data […]
The post Cholesterol Drug in Use Since 1975 Could Prevent COVID-19 Lung Damage, Study Shows first appeared on The Florida Star | The Georgia Star.
